Patent: 9,744,138
✉ Email this page to a colleague
Summary for Patent: 9,744,138
Title: | Treatment method and product for uterine fibroids using purified collagenase |
Abstract: | The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid. |
Inventor(s): | Leppert; Phyllis Carolyn (Salt Lake City, UT), Wegman; Thomas L. (N. Merrick, NY), Taylor; Darlene K. (Burlington, NC) |
Assignee: | BioSpecifics Technologies Corp. (Lynbrook, NY) Duke University (Durham, NC) North Carolina Central University (Durham, NC) |
Application Number: | 14/213,910 |
Patent Claims: | see list of patent claims |
Details for Patent 9,744,138
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2033-03-15 |
Auxilium Pharmaceuticals, Inc. | XIAFLEX | collagenase clostridium histolyticum | For Injection | 125338 | 02/02/2010 | ⤷ Try a Trial | 2033-03-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |